These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3512590)

  • 21. The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics.
    Asplin CM; Hartog M; Goldie DJ
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):330-8. PubMed ID: 580135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin antibodies and the control of diabetes.
    Dixon K; Exon PD; Malins JM
    Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous insulin needs. Relationship with duration of diabetes, C-peptidemia, insulin antibodies, and retinopathy.
    Haumont D; Dorchy H; Toussaint D; Despontin M
    Helv Paediatr Acta; 1982 May; 37(2):143-50. PubMed ID: 7047466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control.
    Radermecker RP; Renard E; Scheen AJ
    Diabetes Metab Res Rev; 2009 Sep; 25(6):491-501. PubMed ID: 19496088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of the insulin antibody titre in severe form of diabetes mellitus].
    Pliats OM; Alekseev IuP
    Probl Endokrinol (Mosk); 1977; 23(3):12-4. PubMed ID: 887624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum IRI in insulin-treated diabetics during a 24-hour period.
    Rasmussen SM; Heding LG; Parbst E; Volund A
    Diabetologia; 1975 Apr; 11(2):151-8. PubMed ID: 1149948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interrelations of blood levels of contrainsular hormones and titers of insulin antibodies in diabetics treated with insulin].
    Vakov L
    Vutr Boles; 1986; 25(6):70-3. PubMed ID: 3551331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-insulin IgE in diabetics.
    Kumar D
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1159-64. PubMed ID: 591613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin, pancreatic polypeptide, and glucagon antibodies in insulin-dependent diabetes mellitus.
    Asplin CM; Hollander P; Pecoraro RE; Brodsky J; Palmer JP
    Diabetes Care; 1981; 4(3):337-42. PubMed ID: 7047110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
    Kühnau J; Rüdiger H; Goetz K
    Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The bioavailability of circulating antibody-bound insulin following insulin withdrawal in Type 1 (insulin-dependent) diabetes.
    Vaughan NJ; Matthews JA; Kurtz AB; Nabarro JD
    Diabetologia; 1983 May; 24(5):355-8. PubMed ID: 6347783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of insulin antibodies on insulin dose and diabetic control.
    Walford S; Allison SP; Reeves WG
    Diabetologia; 1982 Feb; 22(2):106-10. PubMed ID: 7037511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients.
    Emanuelli G; Gatti G; Calcamuggi G; Anfossi G; Cotto A; Marcarino C; Camussi G; Ottone G
    Panminerva Med; 1981; 23(2):81-8. PubMed ID: 7033894
    [No Abstract]   [Full Text] [Related]  

  • 35. Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistance.
    Capaldo B; Napoli R; Di Marino L; Picardi A; Riccardi G; Sacca L
    J Clin Endocrinol Metab; 1988 Nov; 67(5):893-8. PubMed ID: 3053749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A method for the determination of plasma insulin antibodies and its application in normal and diabetic subjects.
    Sebriakova M; Little JA
    Diabetes; 1973 Jan; 22(1):30-40. PubMed ID: 4734254
    [No Abstract]   [Full Text] [Related]  

  • 37. Diabetic control in patients treated with once or twice-daily insulin injections, including a comparison of conventional beef and highly purified pork insulins.
    Gray RS; Borsey DQ; Fraser DM; Kurtz AB; Rainbow S; Smith AF; Duncan LJ; Clarke BF
    Diabetologia; 1981 Sep; 21(3):206-10. PubMed ID: 7028552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical observation on brittle diabetes.
    Lev-Ran A
    Arch Intern Med; 1978 Mar; 138(3):372-6. PubMed ID: 629631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin.
    Asplin CM; Hartog M; Goldie DJ
    Diabetologia; 1978 Feb; 14(2):99-105. PubMed ID: 631462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of anti-insulin antibodies on glycemic control in insulin treated diabetic patients.
    Sakata S; Matsuda M; Komaki T; Miura K
    Immunol Invest; 1987 May; 16(3):263-71. PubMed ID: 3311984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.